- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06345326
Greater Occipital Nerve Block Versus Pulse Radiofrequency in Migraine (GON-B/PRF)
April 2, 2024 updated by: Dr. Ülkü Sabuncu, Adiyaman University Research Hospital
Comparison of the Clinical Effectiveness of Repeated Ultrasound-guided Greater Occipital Nerve Blocks and Greater Occipital Nerve Pulse RF in the Treatment of Migraine
The aim of the study is to evaluate the clinical efficacy of the repeated greater occipital nerve(GON) blokcs with GON pulse radiofreaquency (PRF)
Study Overview
Detailed Description
The nerve blocks will be performed at the Cervical-2 (C2) level with ultrasound guidance.Also , the PRF will be done as above proximally.
Study Type
Interventional
Enrollment (Estimated)
68
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey, 06680
- Recruiting
- Ankara City Hospital Bilkent
-
Contact:
- Sukriye Dadali, MD
- Phone Number: +905333316636
- Email: sukriyedadali@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- ICHD- migraine with minimum 4 attacks
- no benefit with proflactic therapies
Exclusion Criteria:
- primary headhache other than migraine according to ICHD
- the change of medical teatment of migrane in last 1 month.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Repeated greater occipital nerve block
In this arm, all the participiants will receive ultrasound guided greater occipital nerve block for a week, for 4 weeks with ultrasound guidiance at the level C2
|
The nerve block will be done by ultrasound guidiance at the C2 level with a 22 gauge 5 cm needle inplane direction.
The pulse radiofrequency will be done as defined with a radiofrequency cannula- 5 cm with an active tip of 2mm.
Other Names:
|
Experimental: Greater occipital nerve pulse radiofrequency
In this arm, all the participiants will receive ultrasound guided greater occipital nerve pulse radiofrequency with ultrasound guidiance at the level C2
|
The nerve block will be done by ultrasound guidiance at the C2 level with a 22 gauge 5 cm needle inplane direction.
The pulse radiofrequency will be done as defined with a radiofrequency cannula- 5 cm with an active tip of 2mm.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
NRS
Time Frame: Before the application then every month following the intervention for 3 months
|
Numeric rating scala
|
Before the application then every month following the intervention for 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Complications
Time Frame: Before the application then every month following the intervention for 3 months
|
vertigo, dizzines, hypotension , bleeding, local pain ect.
|
Before the application then every month following the intervention for 3 months
|
the frequency of headhache
Time Frame: Before the application then every month following the intervention for 3 months
|
how many times the headhache occured
|
Before the application then every month following the intervention for 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 15, 2023
Primary Completion (Estimated)
March 30, 2024
Study Completion (Estimated)
April 30, 2024
Study Registration Dates
First Submitted
March 27, 2024
First Submitted That Met QC Criteria
April 2, 2024
First Posted (Actual)
April 3, 2024
Study Record Updates
Last Update Posted (Actual)
April 3, 2024
Last Update Submitted That Met QC Criteria
April 2, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- E1-22-3155
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Migraine
-
Austrian Migraine Registry CollaborationMedical University of Vienna; Medical University Innsbruck; Austrian Headache...RecruitingMigraine | Chronic Migraine | Migraine Without Aura | Migraine With Aura | Episodic MigraineAustria
-
Tonix Pharmaceuticals, Inc.PremierCompletedChronic Migraine | Chronic Migraine, Headache | Chronic Migraine Without Aura | Aura MigraineUnited States
-
Harvard University Faculty of MedicineBrigham and Women's Hospital; Palmer Center for Chiropractic Research (PCCR)CompletedMigraine | Migraine Disorders | Migraine Without Aura | Migraine With Aura | Migraine, ClassicUnited States
-
University of FlorenceAzienda Ospedaliera Città della Salute e della Scienza di Torino; University... and other collaboratorsRecruitingMigraine | Chronic Migraine | Migraine Without Aura | Migraine With AuraItaly
-
Notre-Dame Hospital, Montreal, Quebec, CanadaAllerganCompletedChronic Migraine | Migraine Without Aura | Migraine With AuraCanada
-
Glostrup University Hospital, CopenhagenUnknownChronic Migraine | Migraine Without Aura | Migraine With AuraDenmark
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...CompletedMigraine With Aura | Migraine in ChildrenItaly
-
The Cleveland ClinicWithdrawnMigraine | Migraine Disorders | Headache Disorders, Primary | Migraine Headache | Migraine Without Aura | Migraine With Aura | Headache, MigraineUnited States
-
Second Affiliated Hospital, School of Medicine,...SICHUAN CREDIT PHARMACEUTICAL CO., LTD.Not yet recruitingMigraine Without Aura | Migraine With AuraChina
-
Vastra Gotaland RegionCompletedMigraine Without Aura | Migraine With AuraSweden
Clinical Trials on Greater occipital nerve block
-
Keimyung University Dongsan Medical CenterRecruiting
-
Thomas Jefferson UniversityCompleted
-
Assiut UniversityNot yet recruitingCervicogenic Headache
-
Aydin Adnan Menderes UniversityRecruitingBlock | Chronic Migraine, Headache | Occipital NeuralgiaTurkey
-
Mayo ClinicCompletedMigraine Without Aura | Cervicogenic Headache | Occipital NeuralgiaUnited States
-
Eskisehir Osmangazi UniversityCompleted
-
Diskapi Teaching and Research HospitalActive, not recruitingMigraine Disorders | Headache Migraine ChronicTurkey
-
Kasr El Aini HospitalCompletedPosterior Fossa TumorEgypt
-
University Health Network, TorontoNot yet recruitingSpontaneous Intracranial Hypotension
-
Ankara UniversityCompleted